FCH
AUXL

Freestone Capital Holdings’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Freestone Capital Holdings’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-50,500
Closed -$840K – 430
2013
Q2 		$840K Buy
+50,500
New +$806K 0.17% 100

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Freestone Capital Holdings's AUXL Position: Q3 2013 in Review

Freestone Capital Holdings sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2013, closing a stake of 50,500 shares — an estimated $840K sold.

Freestone Capital Holdings first reported a position in AUXL in Q2 2013 and held it in 1 quarter. The position peaked at $840K in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2013.

  • Freestone Capital Holdings reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Freestone Capital Holdings sold 50,500 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2013, an estimated $840K.
  • Freestone Capital Holdings first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Freestone Capital Holdings's AUXILIUM PHARAMCEUTICALS INC position peaked at $840K in Q2 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2013.

Based on Freestone Capital Holdings's 13F filing for Q3 2013, filed 14 Nov 2013.